- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 214.63 | 214.76 |
| R2 | 217.09 | 215.65 |
| R3 | 218.41 | 217.09 |
| PP | 213.31 | 213.31 |
| S1 | 214.63 | 214.76 |
| S2 | 209.53 | 210.98 |
| S3 | 207.07 | 209.53 |
Ratios
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|---|
| ROCE | 24.59 | - | 20.59 | - | 21.58 |
| ROE | 18.66 | - | 15.6 | - | 17.3 |
| EPS | 1.91 | 2 | 1.25 | 1.67 | 1.88 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|---|---|---|---|---|
| No data available | |||||
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basi...
ISIN :INE048B01035
Registered Office
T-210 J,Shahpur Jat
Contact number
+ 91-011-46181100/46109900
Registrars
MCS Ltd
F-65 1st Floor Okhla Industrial Are Phase-I New Delhi-110020
F-65 1st Floor Okhla Industrial Are Phase-I New Delhi-110020
Contact number
+ 91-11-41406149-52
Management
Harsha Raghavan (Chairman)
Manish Gupta (Director)
Open IPO’s
Price Range
₹259 - ₹272
Min. Quantity
55 Shares
Min. investment
₹14,960
Closes on
November 20, 2026
FAQs
The share price of Jagsonpal Pharmaceuticals Ltd on the BSE is - as on -

